register

Medical

New research alliance to advance translation of diagnostics and medicines

Health Industry Hub | May 29, 2024 |

Medical: To accelerate the translation of cutting-edge diagnostics and therapeutics from bench to bed-side, a new collaborative between Northern Health and RMIT University aims to benefit the rapidly growing population of three of Victoria’s growth areas. By 2036, the population of the Northern Health catchment is projected to surge by over 74%.

The Clinical Translational Research Partnership between RMIT University and Northern Health is set to kick off with a focus on enhancing outcomes for patients with cancer, blood disorders, and chronic diseases. Drawing upon the strengths of both institutions in fields like imaging, spectroscopy, immunology, and pharmacology, the partnership aims to pioneer breakthrough research.

Professor Catherine Itsiopoulos, Associate Deputy Vice Chancellor of the Bundoora Health Precinct at RMIT, underscored the significance of preparing future healthcare practitioners to deliver targeted, innovative care.

She emphasised, “Our Clinical Research Translation Partnership will connect clinicians, researchers and academic leaders to ideate and solve healthcare priorities for diverse communities in Melbourne’s north.

“This partnership provides real opportunities to leverage collaboration. We are excited to be enabling immediate translation of evidence-based research in diagnostics, therapeutics and clinical practice focused on cancer, immunology and chronic disease for better patient outcomes.”

Associate Professor Prahlad Ho, Chair of the Research Executive Committee at Northern Health, highlighted the partnership’s role in enhancing healthcare access for residents north of Melbourne “including delivery of innovative clinical trial capabilities as well as novel biomarkers in our multicultural population.”

“Northern Health’s partnership with RMIT will allow a pipeline for the rapid and effective translation of key technological advances into clinical use,” added A/Professor Ho.

The collaboration between Northern Health and RMIT will serve as a hub for clinical trials, particularly in cancer research and nanoparticle diagnostics.

Beyond its research objectives, the partnership is poised to address workforce needs by cultivating a skilled talent pool capable of driving healthcare innovation. Through initiatives like offering Master’s and PhD positions, the collaboration also aims to groom the next generation of medical researchers.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians unveil Novartis and BMS practice-changing trial results

Clinicians unveil Novartis and BMS practice-changing trial results

Health Industry Hub | June 24, 2024 |

Pharma News: Australia, known for its alarming melanoma rates, witnesses one person diagnosed with the disease every 30 minutes, and […]

More


News & Trends - Pharmaceuticals

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Health Industry Hub | June 24, 2024 |

Pharma News: Heart failure is a significant health concern in Australia, affecting approximately half a million people, with over 67,000 […]

More


News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific's intracoronary imaging system

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices […]

More


Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for […]

More


This content is copyright protected. Please subscribe to gain access.